Global Orthobiologics Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

The global orthobiologics market size was generated $4.93 billion in 2018 and is projected to reach $6.93 billion by 2026, registering a CAGR of 4.7% from 2019 to 2026. The research offers a detailed analysis on changing market dynamics, key investment pockets, major segments, and market competition.

Surge in global geriatric population, which is prone to various diseases such as osteoarthritis and others, increase in awareness of orthobiologics, rise in demand for advanced treatment, surge in obesity, and rise in number of sports and road accidents are other factors that drive the growth of the global orthobiologics market. However, higher cost of orthobiologics and stringent approval process restrain the growth of the market. Conversely, high growth potential in developing nations and upsurge in demand for advanced treatment create new opportunities for the market growth.

Viscosupplementation products segment to be lucrative through 2026

Among products, the viscosupplementation products segment accounted for half of the overall market share in 2017 and would retain its dominance through 2026. The same would grow at the fastest CAGR of 4.8% during the forecast period. This is due to the increase in geriatric population, rise in prevalence of osteoarthritis, and growth in lifestyle-induced disorders, such as obesity.

Hospitals & ambulatory centers segment to be lucrative through 2026

Among end users, the hospitals & ambulatory centers segment was the largest in 2017, capturing 90% of the market share and would maintain its dominance through 2026. The same segment would grow at the fastest CAGR of 4.4% from 2018 to 2026. This is because these facilities are fully equipped for performing the surgeries and have the skilled professionals to carry out the procedures.

North America to be dominant, Asia-Pacific to exhibit the fastest growth through 2026

North America captured half of the market share in 2017 and is likely to dominate the market through 2026. This is due to rise in the elderly population, favorable reimbursement rates, rise in the prevalence of orthopedic disorders even among younger population, and increase in number of road accidents in the region. However, Asia-Pacific is expected to register the fastest CAGR of 5.7% from 2019 to 2026.

Key players of the industry

Leading market players analyzed in the research include Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc. These market players have adopted various strategies including collaborations, joint ventures, partnerships, expansions, and others to gain a strong position in the industry.

Segmentation:

By Product
Demineralized Bone Matrix (DBM)
Allograft
Bone Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone Substitutes
Others

By Type
Knee
Ankle
Hip
Wrist & Shoulder
Spine
Others

By Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial & Dental Applications

By End User
Hospitals & Ambulatory Centers
Research & Academic Institute
Dental Clinics

The report analyzes and forecasts the orthobiologics market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global orthobiologics market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the orthobiologics market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of orthobiologics market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Report coverage

  • Analysis Period: 2015 – 2026
  • Base Year: 2018
  • Forecast Data: 2019 – 2026
  • Regional Scope: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Report Coverage: Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global orthobiologics capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
  • Focuses on the key orthobiologics manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content

Section 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research

1.5. Analyst tools and models

Section 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Section 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Porters five forces analysis

3.3. Market dynamics

3.3.1. Drivers

3.3.1.1. Rise in incidence of orthopedic diseases & injury
3.3.1.2. Growth in aging population
3.3.1.3. Increase in sports injuries

3.3.2. Restraints

3.3.2.1. High cost of orthobiologics product
3.3.2.2. Stringent approval process

3.3.3. Opportunity

3.3.3.1. Improvement in healthcare infrastructure

3.4. Top player positioning, 2017

Section 4: ORTHOBIOLOGICS MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Demineralized bone matrix (DBM)

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Allograft

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Bone morphogenetic protein (BPM)

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

4.5. Viscosupplementation products

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

4.6. Synthetic bone substitutes

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

4.7. Others

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

Section 5: ORTHOBIOLOGICS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Osteoarthritis & degenerative arthritis

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Spinal fusion

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Fracture recovery

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Soft tissue injuries

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Maxillofacial & dental applications

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

Section 6: ORTHOBIOLOGICS MARKET, BY TYPE

6.1. Overview

6.1.1. Market size and forecast

6.2. Knee

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Ankle

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Hip

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. Wrist & shoulder

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

6.6. Spine

6.6.1. Market size and forecast
6.6.2. Market analysis, by country

6.7. Others

6.7.1. Market size and forecast
6.7.2. Market analysis, by country

Section 7: ORTHOBIOLOGICS MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Hospitals & ambulatory centers

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Research & academic institute

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Dental clinics

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

Section 8: GLOBAL ORTHOBIOLOGICS MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends and opportunities

8.2.1.1. US

8.2.1.1.1. Market size and forecast, by product type
8.2.1.1.2. Market size and forecast, by application
8.2.1.1.3. Market size and forecast, by type
8.2.1.1.4. Market size and forecast, by end user

8.2.1.2. Canada

8.2.1.2.1. Market size and forecast, by product type
8.2.1.2.2. Market size and forecast, by application
8.2.1.2.3. Market size and forecast, by type
8.2.1.2.4. Market size and forecast, by end user

8.2.1.3. Mexico

8.2.1.3.1. Market size and forecast, by product type
8.2.1.3.2. Market size and forecast, by application
8.2.1.3.3. Market size and forecast, by type
8.2.1.3.4. Market size and forecast, by end user

8.2.2. North America Orthobiologics Market size and forecast, by product type
8.2.3. North America Orthobiologics Market size and forecast, by application
8.2.4. North America Orthobiologics Market size and forecast, by type
8.2.5. North America Orthobiologics Market size and forecast, by end user
8.2.6. North America Orthobiologics Market size and forecast, by region

8.3. Europe

8.3.1. Key market trends and opportunities

8.3.1.1. Germany

8.3.1.1.1. Market size and forecast, by product type
8.3.1.1.2. Market size and forecast, by application
8.3.1.1.3. Market size and forecast, by type
8.3.1.1.4. Market size and forecast, by end user

8.3.1.2. France

8.3.1.2.1. Market size and forecast, by product type
8.3.1.2.2. Market size and forecast, by application
8.3.1.2.3. Market size and forecast, by type
8.3.1.2.4. Market size and forecast, by end user

8.3.1.3. UK

8.3.1.3.1. Market size and forecast, by product type
8.3.1.3.2. Market size and forecast, by application
8.3.1.3.3. Market size and forecast, by type
8.3.1.3.4. Market size and forecast, by end user

8.3.1.4. Italy

8.3.1.4.1. Market size and forecast, by product type
8.3.1.4.2. Market size and forecast, by application
8.3.1.4.3. Market size and forecast, by type
8.3.1.4.4. Market size and forecast, by end user

8.3.1.5. Spain

8.3.1.5.1. Market size and forecast, by product type
8.3.1.5.2. Market size and forecast, by application
8.3.1.5.3. Market size and forecast, by type
8.3.1.5.4. Market size and forecast, by end user

8.3.1.6. Rest of Europe

8.3.1.6.1. Market size and forecast, by product type
8.3.1.6.2. Market size and forecast, by application
8.3.1.6.3. Market size and forecast, by type
8.3.1.6.4. Market size and forecast, by end user

8.3.2. Europe Orthobiologics Market size and forecast, by product type
8.3.3. Europe Orthobiologics Market size and forecast, by application
8.3.4. Europe Orthobiologics Market size and forecast, by type
8.3.5. Europe Orthobiologics Market size and forecast, by end user
8.3.6. Europe Orthobiologics Market size and forecast, by region

8.4. Asia-Pacific

8.4.1. Key market trends and opportunities

8.4.1.1. Japan

8.4.1.1.1. Market size and forecast, by product type
8.4.1.1.2. Market size and forecast, by application
8.4.1.1.3. Market size and forecast, by type
8.4.1.1.4. Market size and forecast, by end user

8.4.1.2. China

8.4.1.2.1. Market size and forecast, by product type
8.4.1.2.2. Market size and forecast, by application
8.4.1.2.3. Market size and forecast, by type
8.4.1.2.4. Market size and forecast, by end user

8.4.1.3. Australia

8.4.1.3.1. Market size and forecast, by product type
8.4.1.3.2. Market size and forecast, by application
8.4.1.3.3. Market size and forecast, by type
8.4.1.3.4. Market size and forecast, by end user

8.4.1.4. India

8.4.1.4.1. Market size and forecast, by product type
8.4.1.4.2. Market size and forecast, by application
8.4.1.4.3. Market size and forecast, by type
8.4.1.4.4. Market size and forecast, by end user

8.4.1.5. South Korea

8.4.1.5.1. Market size and forecast, by product type
8.4.1.5.2. Market size and forecast, by application
8.4.1.5.3. Market size and forecast, by type
8.4.1.5.4. Market size and forecast, by end user

8.4.1.6. Rest of Asia-Pacific

8.4.1.6.1. Market size and forecast, by product type
8.4.1.6.2. Market size and forecast, by application
8.4.1.6.3. Market size and forecast, by type
8.4.1.6.4. Market size and forecast, by end user

8.4.2. Asia-Pacific Orthobiologics Market size and forecast, by product type
8.4.3. Asia-Pacific Orthobiologics Market size and forecast, by application
8.4.4. Asia-Pacific Orthobiologics Market size and forecast, by type
8.4.5. Asia-Pacific Orthobiologics Market size and forecast, by end user
8.4.6. Asia-Pacific Orthobiologics Market size and forecast, by region

8.5. LAMEA

8.5.1. Key market trends and opportunities

8.5.1.1. Brazil

8.5.1.1.1. Market size and forecast, by product type
8.5.1.1.2. Market size and forecast, by application
8.5.1.1.3. Market size and forecast, by type
8.5.1.1.4. Market size and forecast, by end user

8.5.1.2. Saudi Arabia

8.5.1.2.1. Market size and forecast, by product type
8.5.1.2.2. Market size and forecast, by application
8.5.1.2.3. Market size and forecast, by type
8.5.1.2.4. Market size and forecast, by end user

8.5.1.3. South Africa

8.5.1.3.1. Market size and forecast, by product type
8.5.1.3.2. Market size and forecast, by application
8.5.1.3.3. Market size and forecast, by type
8.5.1.3.4. Market size and forecast, by end user

8.5.1.4. Rest of LAMEA

8.5.1.4.1. Market size and forecast, by product type
8.5.1.4.2. Market size and forecast, by application
8.5.1.4.3. Market size and forecast, by type
8.5.1.4.4. Market size and forecast, by end user

8.5.2. LAMEA Orthobiologics Market size and forecast, by product type
8.5.3. LAMEA Orthobiologics Market size and forecast, by application
8.5.4. LAMEA Orthobiologics Market size and forecast, by type
8.5.5. LAMEA Orthobiologics Market size and forecast, by end user
8.5.6. LAMEA Orthobiologics Market size and forecast, by region

Section 9: COMPANY PROFILES

9.1. ARTHREX, INC.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio

9.2. EXACTECH, INC.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments

9.3. GLOBUS MEDICAL INC.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance

9.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION (DERMA SCIENCES INC.)

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance

9.5. JOHNSON & JOHNSON (DEPUY SYNTHES)

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments

9.6. MEDLINE INDUSTRIES, INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating product segments
9.6.4. Product Portfolio

9.7. NUVASIVE INC.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments

9.8. STRYKER CORPORATION

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. WRIGHT MEDICAL GROUP, INC.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments

9.10. ZIMMER BIOMET HOLDINGS, INC

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers